Utama › Mieloma Pelbagai › New Jersey › Edison
Kajian klinikal Mieloma Pelbagai di Edison, NJ
22 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Edison (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 3
- Astera Cancer Care, East Brunswick · 6 mi jauh
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Mengambil pesertaFasa 3
- Astera Cancer Care, East Brunswick · 6 mi jauh
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Mengambil pesertaFasa 3
- MSK Basking Ridge, Basking Ridge · 15 mi jauh
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Mengambil pesertaFasa 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauh
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Mengambil pesertaFasa 3
- MSK Basking Ridge, Basking Ridge · 15 mi jauh
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Mengambil pesertaFasa 3
- Research Site, East Brunswick · 6 mi jauh
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Mengambil pesertaKajian pemerhatian
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Mengambil pesertaFasa awal 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi jauh
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Mengambil pesertaFasa 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi jauh
A Dietary Study for People With Multiple Myeloma
Mengambil peserta
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Mengambil pesertaFasa 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Mengambil peserta
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauh
Kajian Mieloma Pelbagai di bandar lain
- New York City, NY60 kajian
- Boston, MA42 kajian
- Atlanta, GA41 kajian
- Houston, TX38 kajian
- Durham, NC37 kajian
- Nashville, TN32 kajian
- Denver, CO27 kajian
- Rochester, MN24 kajian
- St. Louis, MO24 kajian
- Columbus, OH24 kajian
- Baldwin Park, CA23 kajian
- Chicago, IL22 kajian
Kajian lain di Edison
- Kanser Payudara68 kajian
- Kanser Paru-paru Bukan Sel Kecil47 kajian
- Kanser (semua jenis)33 kajian
- Kanser Prostat29 kajian
- Kanser Kolorektal23 kajian
- Kanser Paru-paru23 kajian
- Kanser Pundi Kencing21 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari20 kajian
- Leukemia Mieloid Akut20 kajian
- Kanser Endometrium19 kajian
- Karsinoma Urotelial (Sel Transisi)18 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.